Literature DB >> 34044401

The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study.

Catharina C Moor1, Nelleke C Tak van Jaarsveld1, Catherine Owusuaa2, Jelle R Miedema1, Sara Baart3, Carin C D van der Rijt2, Marlies S Wijsenbeek1.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease with a heterogeneous disease course. Timely initiation of palliative care is often lacking. The surprise question "Would you be surprised if this patient died within the next year?" is increasingly used as a clinical prognostic tool in chronic diseases but has never been evaluated in IPF.
OBJECTIVE: We aimed to evaluate the predictive value of the surprise question for 1-year mortality in IPF.
METHODS: In this prospective cohort study, clinicians answered the surprise question for each included patient. Clinical parameters and mortality data were collected. The sensitivity, specificity, accuracy, negative, and positive predictive value of the surprise question with regard to 1-year mortality were calculated. Multivariable logistic regression analysis was performed to evaluate which factors were associated with mortality. In addition, discriminative performance of the surprise question was assessed using the C-statistic.
RESULTS: In total, 140 patients were included. One-year all-cause mortality was 20% (n = 28). Clinicians identified patients with a survival of <1 year with a sensitivity of 68%, a specificity of 82%, an accuracy of 79%, a positive predictive value of 49%, and a negative predictive value of 91%. The surprise question significantly predicted 1-year mortality in a multivariable model (OR 3.69; 95% CI 1.24-11.02; p = 0.019). The C-statistic of the surprise question to predict mortality was 0.75 (95% CI 0.66-0.85).
CONCLUSIONS: The answer on the surprise question can accurately predict 1-year mortality in IPF. Hence, this simple tool may enable timely focus on palliative care for patients with IPF.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Advance care planning; End of life; Idiopathic pulmonary fibrosis; Interstitial lung disease; Palliative care; Prognostic tool

Mesh:

Year:  2021        PMID: 34044401      PMCID: PMC8491469          DOI: 10.1159/000516291

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  31 in total

1.  Cultural Differences in Palliative Care in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Marlies Wijsenbeek; Elisabeth Bendstrup; Joy Ross; Athol Wells
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

2.  Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis.

Authors:  Charles Sharp; Heather Lamb; Nikki Jordan; Adrienne Edwards; Rachel Gunary; Patricia Meek; Ann B Millar; Clare Kendall; Huzaifa Adamali
Journal:  BMJ Support Palliat Care       Date:  2017-06-30       Impact factor: 3.568

3.  Palliative care and location of death in decedents with idiopathic pulmonary fibrosis.

Authors:  Kathleen O Lindell; Zhan Liang; Leslie A Hoffman; Margaret Q Rosenzweig; Melissa I Saul; Joseph M Pilewski; Kevin F Gibson; Naftali Kaminski
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

4.  Interstitial lung disease and specialist palliative care access: a healthcare professionals survey.

Authors:  Jee Whang Kim; Sandra Olive; Steve Jones; Muhunthan Thillai; Anne-Marie Russell; Miriam J Johnson; Andrew Wilson
Journal:  BMJ Support Palliat Care       Date:  2020-06-19       Impact factor: 3.568

5.  Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer.

Authors:  Crystal E Brown; Ruth A Engelberg; Elizabeth L Nielsen; J Randall Curtis
Journal:  Ann Am Thorac Soc       Date:  2016-05

6.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Authors:  T E King; J A Tooze; M I Schwarz; K R Brown; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

7.  Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit.

Authors:  Zhan Liang; Leslie A Hoffman; Mehdi Nouraie; Daniel J Kass; Michael P Donahoe; Kevin F Gibson; Melissa I Saul; Kathleen O Lindell
Journal:  J Palliat Med       Date:  2016-10-18       Impact factor: 2.947

Review 8.  Integrating Advance Care Planning Into Practice.

Authors:  Laura E Dingfield; Joshua B Kayser
Journal:  Chest       Date:  2017-03-07       Impact factor: 9.410

9.  Early referral to palliative care services in patients with IPF: a tool to take a step forward.

Authors:  Paola Faverio; Federica De Giacomi; Grazia Messinesi; Alessia Fumagalli; Fabrizio Luppi
Journal:  BMJ Support Palliat Care       Date:  2019-08-29       Impact factor: 4.633

10.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

View more
  1 in total

Review 1.  Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study.

Authors:  Jiaqi Di; Xuanlin Li; Jingjing Yang; Luguang Li; Xueqing Yu
Journal:  Risk Manag Healthc Policy       Date:  2022-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.